Literature DB >> 15900410

Expression of p57KIP2 in infantile hemangioma.

Ricardo Drut1, Rosa Mónica Drut.   

Abstract

AIM: To compare the expression of p57 as indirect marker of genomic imprinting of CDKN1C in a series of infantile hemangiomas (IH) of patients with and without Beckwith-Wiedemann syndrome.
MATERIALS AND METHODS: Cases of mammary, salivary gland, liver (one each), and placental (2 cases) capillary hemangiomas all with histological features akin to IH as well as typical examples of cutaneous (8 cases) IH were analyzed by immunohistochemistry with antibody against p57(KIP2). This protein is the product of CDKN1C an imprinted, maternally expressed gene. The liver hemangioma and both chorioangiomas were from patients with Beckwith-Wiedemann syndrome. Positive and negative controls included normal placental tissue and complete hydatidiform mole, respectively. Positive staining was localized to nuclei.
RESULTS: Endothelial cells from the skin, breast and salivary gland hemangiomas were p57(KIP2) positive while chorioangiomas and liver IH presenting in patients with Beckwith-Wiedemann syndrome were negative. Controls reacted appropriately.
CONCLUSIONS: Endothelial cells of IH not associated with BWS normally express p57(KIP2) while chorioangiomas and IH of the liver associated with BWS do not. These results suggest that the BWS IH may result from dysregulation of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900410     DOI: 10.1007/s10735-005-2255-5

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  12 in total

1.  Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2.

Authors:  D H Castrillon; D Sun; S Weremowicz; R A Fisher; C P Crum; D R Genest
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

2.  Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects.

Authors:  Michael R DeBaun; Emily L Niemitz; D Elizabeth McNeil; Sheri A Brandenburg; Maxwell P Lee; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2002-01-28       Impact factor: 11.025

3.  Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome.

Authors:  V Grandjean; J Smith; P N Schofield; A C Ferguson-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Nonimmune fetal hydrops and placentomegaly: diagnosis of familial Wiedemann-Beckwith syndrome with trisomy 11p15 using FISH.

Authors:  R M Drut; R Drut
Journal:  Am J Med Genet       Date:  1996-03-15

5.  GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.

Authors:  P E North; M Waner; A Mizeracki; M C Mihm
Journal:  Hum Pathol       Date:  2000-01       Impact factor: 3.466

6.  Extracutaneous infantile haemangioma is also Glut1 positive.

Authors:  R M Drut; R Drut
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

7.  A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.

Authors:  P E North; M Waner; A Mizeracki; R E Mrak; R Nicholas; J Kincannon; J Y Suen; M C Mihm
Journal:  Arch Dermatol       Date:  2001-05

8.  Loss of CpG methylation is strongly correlated with loss of histone H3 lysine 9 methylation at DMR-LIT1 in patients with Beckwith-Wiedemann syndrome.

Authors:  Ken Higashimoto; Takeshi Urano; Kazumitsu Sugiura; Hitomi Yatsuki; Keiichiro Joh; Wei Zhao; Mayumi Iwakawa; Hirofumi Ohashi; Mitsuo Oshimura; Norio Niikawa; Tsunehiro Mukai; Hidenobu Soejima
Journal:  Am J Hum Genet       Date:  2003-08-29       Impact factor: 11.025

9.  p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.

Authors:  S-Y Jun; J Y Ro; K-R Kim
Journal:  Histopathology       Date:  2003-07       Impact factor: 5.087

10.  Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome.

Authors:  N Diaz-Meyer; C D Day; K Khatod; E R Maher; W Cooper; W Reik; C Junien; G Graham; E Algar; V M Der Kaloustian; M J Higgins
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

View more
  1 in total

1.  Differential expression of ABH histo-blood group antigens and LAMPs in infantile hemangioma.

Authors:  V Sarafian; D Dikov; M Karaivanov; V Belovejdov; P Stefanova
Journal:  J Mol Histol       Date:  2006-03-29       Impact factor: 2.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.